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Background: This feasibility study is intended to assess the acceptability of home-based task-specific reach-to-grasp
(RTG) training for people with stroke, and to gather data to inform recruitment, retention, and sample size for a
definitive randomized controlled trial.
Methods/design: This is to be a randomized controlled feasibility trial recruiting 50 individuals with upper-limb
motor impairment after stroke. Participants will be recruited after discharge from hospital and up to 12 months
post-stroke from hospital stroke services and community therapy-provider services. Participants will be assessed at
baseline, and then electronically randomized and allocated to group by minimization, based on the time
post-stroke and extent of upper-limb impairment. The intervention group will receive 14 training sessions,
each 1 hour long, with a physiotherapist over 6 weeks and will be encouraged to practice independently
for 1 hour/day to give a total of 56 hours of training time per participant. Participants allocated to the control
group will receive arm therapy in accordance with usual care. Participants will be measured at 7 weeks
post-randomization, and followed-up at 3 and 6 months post-randomization. Primary outcome measures for
assessment of arm function are the Action Research Arm Test (ARAT) and Wolf Motor Function Test (WMFT).
Secondary measures are the Motor Activity Log, Stroke Impact Scale, Carer Strain Index, and health and social care
resource use. All assessments will be conducted by a trained assessor blinded to treatment allocation. Recruitment,
adherence, withdrawals, adverse events (AEs), and completeness of data will be recorded and reported.
Discussion: This study will determine the acceptability of the intervention, the characteristics of the population
recruited, recruitment and retention rates, descriptive statistics of outcomes, and incidence of AEs. It will provide the
information needed for planning a definitive trial to test home-based RTG training.
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Stroke is a major cause of disability worldwide [1]. In
England alone, approximately 110,000 people have a
stroke each year, and many of these patients require con-
tinued rehabilitation after discharge from hospital [2].
However, the UK National Stroke Strategy published in
2007 stated that only 50% of patients with stroke receive
rehabilitation that meets their needs in the first 6 months
post-discharge and only 20% in the next 6 months [3].
This inconsistency of service provision was also identified
by the Care Quality Commission [4], and has led to a UK-
wide drive to increase the provision of community-based
rehabilitation services for people with stroke [5,6].
Up to 85% of stroke survivors experience hemiparesis,
which results in impaired movement of the arm [7]. Of
these survivors, a large proportion (46 to 95%) is esti-
mated to have continuing problems at 6 months after on-
set [8]. Loss of arm function has been shown to adversely
affect quality of life and subjective wellbeing after stroke
[9,10]. To improve outcomes, it has been recognized that
research to determine the most effective interventions for
promoting arm recovery should be a priority [11,12].
A Cochrane systematic review was recently conducted
to address whether home-based upper-limb therapy pro-
grams are effective for recovery of function for people
after stroke. The review found only four trials that met
the inclusion criteria, and these provided insufficient evi-
dence to answer the question [13]. Furthermore, none of
the four tested interventions were suitable for partici-
pants with a severely affected limb. The review con-
cluded that high-quality randomized controlled trials
(RCTs) of therapy programs specifically targeting the
upper limb are needed, and that these should be inter-
ventions in which participants are visited by health pro-
fessionals at home.
Theoretically, home-based rehabilitation may be more
beneficial than hospital-based or outpatient treatment by
allowing repeated practice of occupationally embedded
tasks in the person’s own environment, in accordance with
the ‘specificity of learning’ principle [14]. This principle
predicts that learning of a new skill is enhanced when
conditions of practice match those of the task in real life.
Practicing movement within tasks or actions has been
termed ‘task-specific training’, and there is mounting the-
oretical evidence for its use in neurological rehabilitation
of the upper limb, with massed practice of tasks as its cen-
tral tenet [15]. The theory is supported by robust findings
from research on skill acquisition, showing experience-
dependent behavioral and neural changes in animals and
humans [16-19]. Many motor functions are mediated
through specific neural networks [20]. Therefore, if a spe-
cific action is to be improved, it would seem important to
train and strengthen a network to regain that action rather
than expecting training to generalize to many and variedupper-limb tasks [21-23]. The effectiveness of repetitive
task training is partially supported by the findings of a
Cochrane systematic review, in which the authors found
clear benefits of repetitive task training for the function of
the lower limb , but not for that of the upper limb [24].
However, the authors stated that the latter finding was
‘very tentative’ owing to the paucity of studies and me-
thodological limitations, and recommended further re-
search. Another review of stroke rehabilitation trials
encompassing a wider spectrum of therapy interventions
concluded that interventions focusing on high-intensity
and repetitive task-specific practice showed the most prom-
ise for improving motor recovery [25]. There is a need for a
well-designed trial to test the hypothesis that task-specific
upper-limb training at home provides a significant im-
provement over the usual care currently provided for pa-
tients with arm impairment in the months after stroke.
Based on the theoretical framework underpinning task-
specific training, it is reasonable to hypothesize that to be
effective, training must target actions that are used fre-
quently in a person’s everyday life. When stroke survivors
have been asked about their goals for a therapy program
for their affected arm, many of the goals involved RTG ac-
tivities [26,27]. Reaching to grasp is an essential action
used to perform everyday functions such as retrieving ob-
jects (for example, clothes, food, and drink), and is used
more frequently than other arm actions such as gesturing,
stabilizing objects, or providing support [28]. An effective
intervention specifically targeting RTG tasks therefore has
the potential to improve a stroke survivor’s ability to per-
form activities of daily living.
A fundamental problem for RTG task-specific training
for stroke is that many patients do not have sufficient
motor control to perform the whole action, therefore a
definition of the intervention that will suit a wide range of
impairments is needed. More severely impaired individ-
uals could practice ‘part’ of an RTG task; therefore, for the
purposes of this study, RTG task-specific training will be
defined as a combination of whole-task training and part-
practice. Part-practice will be undertaken through seg-
mentation, that is, the RTG action will be broken down
into components (for example, shoulder flexion, elbow ex-
tension, finger opening) that can be practiced separately
or in combination, providing they are goal-directed.
Hubbard has recommended that to have the best chance
of being effective, task-specific practice should be inten-
sive [15]. Decisions about the frequency of the interven-
tion therefore need to reflect the amount of therapy that
can be reasonably delivered by community therapy ser-
vices and how much patients can be asked to practice in
the absence of a therapist. The Extremity Constraint In-
duced Therapy Evaluation (EXCITE) trial of constraint in-
duced movement therapy for the upper limb, which
resulted in significant improvement in outcome, delivered
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pants at 3 to 9 months post-stroke [29]. To approach the
same number of hours with a schedule that is more likely
to fit within the constraints of UK community rehabilita-
tion, it was decided that a prescription of 14 visits of 1
hour each over the course of 6 weeks with up to 1 hour a
day of self-monitored practice should be used. Combined
with the therapist-supervised sessions, the total prescrip-
tion will be 56 hours of practice.
Before designing a definitive trial, the acceptability of
the intervention, the characteristics of the participating
population, recruitment and retention rates, descriptive
estimates of outcome, and incidence of adverse events
(AEs) need to be determined. This paper outlines the ob-
jectives and design of a feasibility study, and describes
how the data generated will be used to inform a Phase 3
trial.Study objectives
The aims of this feasibility trial are as follows.
1. To determine the characteristics of the sample
entering the feasibility trial for its representation of
the target population and to determine the most
appropriate primary outcome measure for the
sample, that is, the Action Research Arm Test
(ARAT) or the Wolf Motor Function Test (WMFT).
2. To estimate identification and recruitment rates for
the trial across multiple sites.
3. To determine the frequency and content of upper-
limb treatment delivered to both the intervention
and control groups.
4. To estimate the adherence of RTG group
participants to the prescribed schedule.
5. To estimate the completeness of outcome data.
6. To calculate sample sizes for a subsequent definitive
trial, based on measured changes in performance for
both the control and intervention groups.
7. To collect and synthesize the views from
participants in the intervention group to determine
acceptability of the RTG therapy.
8. To determine the frequency of AEs in both groups.
9. To collect data on health and social care resource use
to inform data-collection methods for an economic
evaluation in the subsequent definitive trial.Methods
Study design
This study is a two-arm, multicenter, assessor-blinded
feasibility RCT of task-specific RTG treatment. The con-
trol group will receive arm therapy in accordance with
usual care. The trial design is summarized in Figure 1.Participant recruitment
Participants will be recruited from the stroke services of
three National Health Service (NHS) Hospital Trusts
and community therapy services, covering an area with a
population of 918,300 [30]. This trial intends to recruit
50 participants over a period of 15 months. Eligibility
criteria are designed to be as inclusive as possible to pro-
mote the applicability of the evidence to service delivery.
Inclusion criteria
Patients will be eligible for the study if they: have been
diagnosed as having had a stroke (the stroke does not
have to be the first in their lifetime); are discharged
home (that is, their permanent address, which may be a
care home or sheltered accommodation); and have a re-
sidual deficit in upper-limb movement, defined as being
unable to pick up a 6-mm ball bearing from the table
top, between index finger and thumb, and place it on a
shelf 370 mm above the table (pinch task from the
ARAT [31]). This disability will be judged to be the con-
sequence of the recent stroke.
To participate, patients must provide informed con-
sent in accordance with the Mental Capacity Act, 2005
[32]. Non-English speakers will be included if the aid of
an interpreter is available via the NHS. Patients with
aphasia can be included, and the consent procedure will
be facilitated using pictorial aphasia-friendly participant
information booklets and communication other than
spoken language (for example, gestures, strategic use of
environmental cues).
Exclusion criteria
Patients will not be eligible if they: have pre-stroke path-
ology of the stroke-affected upper limb preventing RTG,
are unable to lift their hand off their lap when asked to
place their hand behind their head (a Gross Motor task
from the ARAT), have severe fixed contractures of elbow
or wrist (that is, grade 4 on the modified Ashworth scale
[33], or are more than 12 months post-stroke.
Potential participants will be identified by a clinician
who will give the person an invitation letter and patient
information sheet describing the study. The clinician will
then ask the person’s permission to pass their contact
details onto the research team. If the patient agrees, a
member of the research team will arrange to visit the pa-
tient at home to undertake the consent procedure.
Demographic data will be collected at the time of re-
cruitment to allow description of the sample. These data
will include age, gender, hand dominance, stroke classifi-
cation, date of stroke, and co-morbidities. As a further
descriptor, cognitive impairment will be assessed with
the Montreal Cognitive Assessment [34].
Any patients who are eligible to take part in the trial but
do not wish to participate will be asked if they consent to
Figure 1 Design of the feasibility randomized controlled trial.
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screening log. This is to describe the sample with respect
to the target population. These individuals will be given
an information leaflet to help them to decide what, if any,
information they consent to being recorded and kept by
the research team. Retaining personal details of people de-
clining participation is particularly important in this study,
because people will be allowed to join the study up to 1
year post-stroke and they may encounter therapists in dif-
ferent services over the course of this time. Keeping the
identifying information will help to ensure that the wishes
of people who ask not to be approached about the trial
again are honored. The screening log will allow data col-
lection in accordance with the 2010 CONSORT statement
[35], and help to ensure that we do not approach patientswho have been recruited to other research studies that
would be confounded by later participation in our trial.
Patients deemed eligible for the trial but who decline to
participate will be asked if they consent to the following in-
formation being recorded on the centrally held screening
log: initials, NHS number, date of birth, gender, date of
stroke, reason for non-participation, and level of post-
stroke upper-limb impairment at the time of approach. A
quick and easy criterion for clinicians to use for logging
impairment level was chosen. They will be asked to deter-
mine whether the individual is able or unable to carry out
two tasks while seated with their back against a chair back
and their affected hand in their lap: 1) ability to reach to
touch their ipsilateral knee; and 2) ability to pick up a can
of drink from a table.
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or without a basic level of hand function are declining to
participate.
Recruitment of carers
In addition to the people with stroke, their carers will be
recruited for interview using a structured questionnaire:
the Caregiver Strain Index (CSI [36]). In all cases, the trial
participant must be in agreement for their carer to be
approached. Information for the carer will be left with the
participant. The carer may then indicate their willingness
to be contacted by the research team by returning a tear-
off slip in a stamped addressed envelope. The person with
stroke may participate even if the carer declines to be
interviewed.
Outcome measurement
Baseline assessments will be conducted within 1 week of
recruitment and before randomization. Outcome assess-
ment will be performed at 7 weeks post-randomization,
and follow-up assessments at 3 and 6 months after
randomization. The assessments will be carried out in the
participant’s home by an assessor who is blinded to group
allocation and who is trained in the assessment proce-
dures. All of the following assessments will be undertaken
at all four time points: ARAT, WMFT, Motor Activity Log
(MAL), and Stroke Impact Scale (SIS). The health and so-
cial care questionnaire and the CSI will be undertaken
only at the follow-up assessments.
One of the objectives of this feasibility trial is to deter-
mine which functional measure should be the primary
outcome measure in a subsequent definitive trial. Two
measures of arm function will be tested to see which will
be most suitable for the sample given the level of func-
tioning of the recruited sample and participants’ prefer-
ences: the ARAT [31] and the WMFT [37]. The ARAT
consists of 19 items focusing on reaching and grasping ob-
jects of different shapes and sizes, and lifting them onto a
shelf, and also has a section for rating gross arm move-
ments. The ARAT is best suited to people who have hand
function; those who are unable to grasp and release will
only be able to score points in the Gross Motor section.
Item scoring is ordinal (0, 1, 2, or 3), with higher values
indicating better performance. The test has high inter-
rater reliability (intra-class coefficient (ICC) = 0.98) and
test–retest reliability (ICC = 0.99) and good validity, and,
in those with hand function, is sensitive to therapy-related
changes after stroke [38,39]. A standardized protocol for
the ARAT will be followed [40], for which high reliability
scores have been established in a multi-center study [41].
The WMFT assesses both isolated arm movements and
performance of functional tasks, and so will suit low-
functioning participants better. In the WMFT, 17 actions
are measured according to time taken to complete themand a quality rating of the use of the affected hand in
attempting the task (graded 0 to 5). The WMFT has high
inter-rater reliability for time scores (ICC = 0.97) [37], for
quality of performance score (ICC = 0.88), and test–retest
reliability (ICC = 0.90 for performance time and ICC =
0.95 for quality ratings) [42]. To help determine the most
appropriate primary outcome measure for a definitive trial,
participants will be asked their opinions of the outcome
measures, and which they consider best reflects meaningful
change. This will be performed using a structured ques-
tionnaire administered by the assessor at the time of the
final follow-up. Assessors will keep a log of aspects of ad-
ministration of the tests that threaten their reliability.
There will be three secondary outcome measures.
1) The MAL. Participants are asked to rate on a six-
point scale the level of use and quality of their arm
movement for performing 28 everyday tasks. The
MAL is a reliable and valid measure for people up to
12 months post-stroke [43].
2) The SIS. This is an interviewer-administered
measure, used to obtain self-report ratings on a five-
point scale of difficulties or restrictions in eight
domains: limb strength, memory and thinking,
mood and emotions, communication, activities of
daily living, indoor and outdoor mobility, hand
function, and social participation. Participants are
also asked to rate their perception of percentage of
their recovery. It has excellent internal consistency
(α = 0.83 to 0.90) and adequate to excellent test–
retest reliability (ICC = 0.7 to 0.92 with the
exception of the Emotion domain (ICC = 0.57)) [44].
3) Caregiver burden will be assessed using the CSI, a
13-question tool that measures strain related to care
provision in the following domains: employment,
financial, physical, social, and time. Participants are
asked to agree or disagree with the statements. The
scale has established internal consistency
(Cronbach’s α = 0.86) and correlates with caregivers’
subjective perceptions of the care giving relationship
and the physical and emotional health of the
caregiver [36].
In addition, an assessment of health and social care
costs will be undertaken. Patients will be asked to
complete a health and social care questionnaire at 3 and
6 months to estimate all condition-related primary and
secondary care costs and use of any social care services.
The cost of delivering task-specific RTG training and
usual care will also be estimated, and details such as ac-
tual time spent by the therapist with the patient, travel
costs, frequency of visits, and equipment used will be
recorded. This is in preparation for economic analysis in
a future Phase 3 trial.
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Data will be collected and retained in accordance with
the UK Data Protection Act 1998 [45], and managed in
accordance with the trial-specific standard operating
procedure for data management.
With their consent, patient details will be passed be-
tween NHS services and the research team by telephone
or in person (that is, not electronically via email or text
message). All patients who provide consent will be allo-
cated a unique study ID. The information linking each
participant’s study ID to their personal details will be kept
securely at the University of the West of England (UWE).
All other patient-related paper records will be anonymized
and stored separately from the personal information.
The electronic database for the trial will be stored on
the secure servers of the University of Bristol with
password-controlled access provided for the UWE re-
search team by the Bristol Clinical Trials and Evaluation
Unit (CTEU). Single data entry with extensive in-built val-
idity checks will be used to reduce the risk of transcription
errors. The study database will include prompts for miss-
ing data, and warnings to alert staff when values are en-
tered that are outside of the expected range or are
inconsistent with other data already entered, or if the type
of value entered is incorrect (for example, a numeric value
entered rather than text).
Randomization
Participants will be randomly allocated to the intervention
or to the usual care groups in a 1:1 ratio after baseline as-
sessment. Randomization will occur via an independent
internet-based service, and the procedure will use
minimization to balance time since stroke, severity of
upper-limb impairment, and group numbers between the
two arms. Time since stroke will be categorized as less than
or equal to 3 calendar months post-stroke, or more than 3
calendar months post-stroke. This 3-month cut off was
chosen to balance between groups the number of partici-
pants within 3 months of stroke, who might be recovering
at a faster rate [46]. Baseline severity will be categorized
using scores on the ARAT in three subgroups defined by
Morris et al. [47] (group 1: score 0 to 3; group 2 score 4 to
28; group 3 score 29 to 56).
The data for the randomization procedure will be en-
tered by the trial manager. He will have no influence over
the allocation to group because the randomization proced-
ure is independent, and he will not be involved in measur-
ing outcome. Post-randomization, the trial manager will
contact the patient and any NHS services involved in the
patient’s care to inform them of the treatment allocation.
Blinding
All research personnel responsible for assessing outcome
will be blinded to the participant’s group. Owing to thenature of this behavioral intervention, those involved in
the delivery of the treatment will not be masked and nor
will the participant. Measures will be taken to minimize
the potential for the assessor to become unblinded. These
will follow the guidelines recommended by Siemonsma
and Walker [48], and include the assessor and research
physiotherapist having separate offices, telephones, and
document-storage facilities, and avoiding discussion about
participants in front of the assessor. The trial manager will
make appointments for the assessment by telephone, and
will use this opportunity to remind participants not to
reveal details of any treatment they have received to the
assessor. Incidents of unblinding will be recorded immedi-
ately after the assessment in a note to file in the case re-
port form. With reference to these notes, the assessor will
be asked to fill in a questionnaire at the end of their in-
volvement in the study to identify whether they know or
have guessed each participant’s group. These data will be
compared with the actual group allocation to determine
the success of the blinding, as recommended by Minns
Lowe et al. [49].Intervention group
To determine the content of the RTG training, the therap-
ist will initially assess the patient’s attempt of the whole
task, and analyze which of its components need to be pri-
oritized for practice. For example, a patient with weak
shoulder flexion may practice reaching by sliding the hand
forward over a non-resistant surface to touch an object or
grasp it. The training tasks should be challenging and pro-
gressively adapted by chaining; that is by practicing first
one part, then practicing that part along with the next
[50]. Patients showing sufficient improvement may pro-
gress in this way to mastery of the whole task.
To optimally standardize the intervention, a detailed
description of the underlying principles of the task-
specific RTG intervention has been developed using the
‘essential components’ of the RTG movement as a struc-
ture [51] (see Additional file 1). An exercise manual
containing 122 exercises has been produced for therapists
to follow (see Additional file 2). Each exercise involves
interacting with objects and the environment, and is set up
to promote practice with joint range and speed of the
movement, that is, close to those characteristics of the task
when performed as a whole RTG action. The therapist can
individualize exercises for patients by advising on or pro-
viding environmental adaptations; for example, by choos-
ing meaningful objects of different sizes, weight, and
shape, or by recommending a starting position for the pa-
tient. Little or no manual guidance will be used. Over the
course of the feasibility study, further exercises may be in-
corporated as new ones are determined by working with
the study participants.
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pants allocated to the RTG training will receive 14 visits,
each lasting 1 hour, from a research therapist over a
period of 6 weeks. This will replace any usual care training
for the upper limb. The frequency of the research thera-
pist’s visits will be three times a week for the first 3 weeks,
twice a week for each of the next 2 weeks, then once in
the final week. The frequency of visits is tapered with the
aim of increasing self-efficacy in practice. The intensity of
practice within each 1-hour session will be dependent on
individual participant’s capabilities, but high numbers of
repetitions will be encouraged, with the aim of delivering
between 100 and 300 repetitions within each 1-hour ses-
sion, in accordance with the findings of a recent feasibility
study into frequency of task-specific training [52]. To fa-
cilitate such a high number of repetitions, clinical experi-
ence has indicated that it is appropriate to limit the
number of exercises prescribed within each session to a
maximum of six, and to a maximum of four for partici-
pants to continue to practice independently. The research
therapist will keep a log of which exercises from the treat-
ment manual are performed, and of the number of repeti-
tions of each exercise.
From the beginning of the intervention phase, the par-
ticipants will be instructed to practice in the absence of
the therapist for 1 hour/day. They will be asked to rec-
ord on a log sheet the number of repetitions of each task
that they complete in their independent practice. There
is no method in place in this feasibility study to check
on the fidelity of these records, as this would have re-
quired resources beyond those available for this study.
The therapist will stress to the participant that an accur-
ate record is important to enable us to determine the
feasibility of the amount of practice prescribed. They will
be requested to record reasons for non-adherence to the
practice schedule. This information will be collected at
the end of the intervention period.
To help participants understand the importance of prac-
tice for recovery and to promote compliance with the
RTG task-specific training, a booklet about recovery from
stroke will be provided (see Additional file 3). The booklet
describes in simple terms the mechanisms of stroke and
the potential for recovery by ‘rewiring’ in the brain
through practice, and also provides contact details of local
resources and services for people with stroke. A recent
Cochrane review on information provision for patients
with stroke and their caregivers showed that providing in-
formation improves patient and carer knowledge of
stroke, improves aspects of patient satisfaction, and re-
duces patient depression scores [53].
Participants receiving the RTG training will be asked
their opinions of the intervention using a structured
questionnaire administered face to face by the research
physiotherapist after their final intervention visit. Withlimited personnel to carry out these interviews, the risk
of bias inherent in using the research therapist for these
interviews was considered preferable to requiring the as-
sessor to do these interviews, as this could cause
unblinding. Data from the interviews will inform the ac-
ceptability of the intervention content and frequency.Control group
The control group will receive arm therapy in accordance
with usual care, which will be delivered by NHS service
therapists. In usual care, the frequency and content of
physiotherapy or occupational therapy for improving
upper-limb function is variable. From consultation with
local therapy services, we found that provision of therapy
varies in intensity, depending on the individual’s care path-
way and the range of community services available. For
example, after discharge from early supported discharge
services, patients with care needs are usually referred to
community intermediate care or rehabilitation teams.
These teams typically provide a service for 6 weeks, and
patients may receive approximately two visits per week
from a qualified therapist, with 30 minutes of the visit fo-
cused on the arm or hand. There may be supplementary
visits from support workers. Other patients may be seen
by a community therapist once a fortnight with no supple-
mentary visits from support staff, and some patients may
not receive any therapy at all. It is unusual to receive arm
therapy beyond 6 months after discharge from hospital.
One of the aims of this feasibility study is to determine
the frequency and content of treatment delivered in both
arms of the trial. Usual care will be captured on recording
sheets that will be completed by NHS service physiothera-
pists and occupational therapists. They will be asked to
record the content, duration, and frequency of upper-limb
treatment, including the number of repetitions of any
functional task training on treatment recording sheets de-
veloped by Donaldson et al. [54].
Participants allocated to the control group will be pro-
vided with a booklet about recovery after stroke, which
is the same as the booklet which will be given to the
intervention group, with the exception that, instead of
information about the RTG training, it will provide de-
tails of the frequency of assessment visits for the study
(see Additional file 4).
Participants in the control group who do not receive
any therapy aimed at improving upper-limb function dur-
ing their participation will receive a single visit from the
research physiotherapist after their final assessment. The
physiotherapist will discuss the patient’s functional limita-
tions and goals with them and, after assessing their move-
ment and function, will provide specific exercises and
advice. If indicated, the physiotherapist is able to refer to
appropriate local therapy services.
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Pain in the shoulder, upper arm and hand and oedema in
the hand are common sequelae of hemiparesis, and are
therefore expected AEs in the study. In addition, falls and
equipment failure leading to injury requiring a visit to hos-
pital or general practitioner will be treated as expected
AEs. It is possible that increased use of the upper limb
may lead to an increase in general activity in the home or
community, and could result in increased likelihood of
falling. The ARAT and WMFT assessments require that
equipment is taken into the participant’s home. Although
every effort will be made to minimize risk, accidents may
happen when using any equipment. Participants will be
specifically asked at each of the assessment visits if they
have experienced any of the expected AEs.
All staff involved in contact with participants will re-
ceive training on identification and reporting of AEs.
Any serious AEs that occur will be reported to the trial
sponsor, and if the chief investigator (CI) considers any
of these to be related to the RTG intervention, these
AEs will be reported immediately to the research ethics
committee that granted approval for the trial. Incidence
of AEs will be collected by the trial manager and
reported quarterly to the trial steering group.
Data analysis
As this is a feasibility study to test the levels of recruit-
ment and retention of participants, and completeness of
data that can be expected within a definitive multicenter
trial, there will be no formal statistical testing, and results
will instead be summarized using descriptive statistics.
Analysis of the centrally held screening log data will lead
to a description of the characteristics of the recruited sam-
ple against the target population, and the percentage of re-
fusals at the recruitment stage. Recruitment rates per
month for each site will be determined. The number of
withdrawals and reasons for withdrawal from the study will
be assessed.
Compliance with the RTG intervention will be assessed
by the number and duration of physiotherapy visits and
the proportion of participants completing the 6-week
intervention. The frequency of use of the exercises, num-
ber of repetitions, and duration of practice of each exer-
cise, both within the physiotherapy sessions, and the
independent practice will be summarized and compared
with the intended exercise frequency and content. The
frequency and content of the treatment received by each
group will be summarized, as will the incidence of
expected AEs and serious AEs. Responses to the partici-
pant questionnaire about the RTG training will be synthe-
sized and examined to determine if any changes should be
made to the intervention.
Completeness of outcome data will be determined, and
data for each of the endpoints will be summarized; themean differences between the arms, with their confidence
intervals, will be presented. Assessment of the sample
scores on the outcome measures, combined with a sum-
mary of participant preference for ARAT and WMFT, will
be carried out to determine which arm function test
should be used as the primary outcome measure for a
phase III trial. Sample sizes for a subsequent phase III trial
will be calculated, based on observed changes from base-
line in performance, for both the control and intervention
groups.
Trial monitoring and management
The trial manager will manage the day-to-day running
of the study. Before the study commences, training ses-
sions for clinical staff involved at each site will be orga-
nized by the UWE research team. These sessions will
ensure that personnel involved fully understand the re-
search protocol, delegation log, and standard operating
procedures for the study.
The UWE research team will meet regularly (ideally fort-
nightly) throughout the trial. The trial steering group, CI
and trial manager will have a teleconference every 4 months
to discuss progress, including recruitment, withdrawals,
treatment compliance, and AEs. The steering group will
provide advice on amendments to protocol if necessary.
The Bristol CTEU, a clinical trials unit registered with
the UK Clinical Research Collaboration, will specify the
randomization scheme, develop and maintain the study
database, and carry out trial analyses in collaboration with
the investigators. An independent data monitoring and
safety committee will not be convened for this pilot study,
as there is very low risk of intervention-related AEs and a
short recruitment, intervention, and follow-up period.
Ethical considerations
The study has been approved by the National Research
Ethics Service, South West Southmead Research Ethics
Committee (REC) (ref number: 10/H0102/83) and the
sponsor’s REC at the Faculty of Health and Life Sciences,
UWE, Bristol. The study has been approved by the Re-
search and Development (R&D) departments responsible
for each site. This study will be conducted in accordance
with the principles of the International Conference for
Harmonisation of Good Clinical Practice (ICH GCP)
guidelines [55] and the Research Governance Framework
for Health and Social Care [56]. Information about pos-
sible benefits and risks of participation will be described in
the patient information sheets. Any amendments to the
trial documents must be approved by the sponsor before
submission to the REC and R&D departments.
The study will be monitored and audited in accordance
with the sponsor’s policy, which is consistent with the Re-
search Governance Framework [56]. All study-related doc-
uments will be made available on request for monitoring
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This is a UWE-sponsored research study, working in col-
laboration with NHS trusts. The University's Clinical Trials
insurance cover provides either legal liability cover or non-
negligent/no-fault compensation cover.
Discussion
Recovery of the upper limb after stroke may take many
months, particularly in those more severely affected [46].
Effective home-based therapy programs are needed to
help improve hand and arm function in the stroke popu-
lation. An important part of developing and evaluating
interventions is to describe them well. There is acknowl-
edged ambiguity in definitions of the content of home-
based therapy programs [13]. This paper, in conjunction
with the publication of the exercise manual (see Additional
file 1; see Additional file 2) and participant booklets (see
Additional file 3; see Additional file 4) aims to provide a
detailed description of the development and planned im-
plementation of the RTG intervention.
At present, few studies have evaluated home-based the-
rapy for the upper limb [13], and designing a trial to be
conducted in a community setting can present new chal-
lenges. Community rehabilitation and therapy services
within the UK are variable in their provision and fragmented
in their organization [57], and similar difficulties have been
reported internationally [58,59]. The stroke pathway passes
through multiple services and organizations, and varies be-
tween catchment areas, so the number of clinical personnel
involved is considerable (about 100 for the area used in this
feasibility study), with high staff turnover. Therefore, putting
into place procedures that are sufficiently flexible for identi-
fying and recruiting potential participants in hospital stroke
services and in the community is important. Devising viable
procedures for recording the demographic information of
people who have been approached but who decline partici-
pation is also essential in order to avoid duplication and to
enable assessment of the characteristics of the recruited
sample with respect to the target population.
Careful planning to overcome the challenges of
community-based stroke-rehabilitation research is essen-
tial to prepare for a trial of adequate size and quality to
assess a home-based upper-limb therapy program. In pre-
vious studies of upper-limb repetitive task training, signifi-
cant methodological limitations have been acknowledged,
for example, refusals to recruitment varied from 4 to 73%
of potential participants [24]. Before designing and
conducting an adequately powered, high-quality RCT of
home-based upper-limb repetitive task training, a feasibility
study should be completed to provide the information ne-
cessary. This paper has defined the aims and objectives of
a feasibility study of home-based RTG training for people
after stroke, and provided a detailed description of the
intervention and study design.Trial status
The first participant was enrolled onto the trial in
December 2011. Recruitment is ongoing, with 46 par-
ticipants enrolled to date.
Additional files
Additional file 1: Description of intervention.
Additional file 2: Reach-to-grasp exercise manual.
Additional file 3: Intervention group Recovery after Stroke booklet.
Additional file 4: Control group Recovery after Stroke booklet.
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